By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Aurinia (Formerly Known as Isotechnika Pharma Inc.) 

5120 - 75th Street

Edmonton  Alberta  T6E 6W2  Canada
Phone: 780-487-1600 Fax: 780-484-4105


Key Statistics

Ownership: Public

Web Site: Aurinia
Symbol: AUPH

Company News
Aurinia (AUPH) Reports Second Quarter 2017 Financial Results, And Provides Operational Highlights 8/11/2017 6:23:41 AM
Aurinia (AUPH) Resolves Temporary Non-Compliance With Nasdaq’s Audit Committee Composition Rule 7/13/2017 6:50:28 AM
After Its Drop, Is Aurinia (AUPH) Stock Now A Buy? 7/13/2017 6:14:33 AM
Aurinia (AUPH) Announces Results Of Annual General Meeting 6/23/2017 6:12:45 AM
Aurinia (AUPH) To Host Annual General Meeting Of Shareholders And Webcast On June 21 In Vancouver, BC 6/21/2017 6:33:07 AM
Aurinia (AUPH) Release: Voclosporin Remission Data From The Phase IIb AURA-LV Study Highlighted At EULAR 2017 6/16/2017 7:28:53 AM
Aurinia (AUPH) Presents Additional Data From Phase IIb AURA-LV Study, Demonstrating Stable Renal Function And Blood Pressure Without Electrolyte Complications Through 48 Weeks 6/5/2017 12:39:26 PM
Aurinia (AUPH) To Participate In Late Breaking Oral Presentations At Two Upcoming Scientific Conferences 5/31/2017 6:45:14 AM
Aurinia (AUPH) Doses First Patient In AURORA Phase III Clinical Trial Of Voclosporin In Lupus Nephritis 5/18/2017 9:00:15 AM
Aurinia (AUPH) Reports First Quarter 2017 Financial Results, Announces Initiation Of Phase III Aurora Clinical Trial, And Provides Operational Highlights 5/15/2017 8:52:10 AM